Tirzepatide vs semaglutide: which is better for weight loss?
Educational only: This page is for general education—not personal medical advice, diagnosis, or treatment. See a licensed clinician for your situation.
Short answer
Both are prescription GLP-1–based therapies with strong trial data in eligible adults. Tirzepatide (dual GIP/GLP-1 agonist) showed greater average weight loss in some head-to-head trials, but individual response, side effects, cost, and insurance coverage vary. A clinician personalizes choice—there is no universal winner.
Detailed answer
Monitoring includes GI tolerance, gallbladder symptoms, and metabolic labs as indicated.
Evidence & references
- SURMOUNT and STEP trial publications
- FDA Mounjaro/Zepbound and Wegovy labels
Also read our Weight loss articles · Dr. Sneh Pandey, MD